Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Elutia
Silver Spring, Maryland, United Stateselutia.com ↗
- Ownership
- Public · ELUT
- Employees
- ~51
- Development stage
- Other
01
Overview
Elutia has commercialized two main product lines—CanGaroo and SimpliDerm—both leveraging its proprietary drug-eluting biomaterial platform. CanGaroo provides an acellular envelope for cardiac devices to reduce infection and fibrotic response; SimpliDerm serves as a human acellular dermal matrix for soft tissue repair. The company’s new product, EluPro, recently received FDA clearance and competes directly with Medtronic’s TYRX in the antibiotic-eluting envelope market. Clinical data suggest that using natural biologics instead of synthetic polymers leads to better remodeling into healthy tissue and less scar formation.
- Therapeutic areas
- OtherCardiovascularNeurology
- Modalities
- Drug-eluting biomaterialsAcellular biologic matrices
- Industry
- Implantable Medical Devices
02
Financials
- Market cap
- $33.3M
- Total revenue
- $12.3M
- Enterprise value
- $4.2M
Beyond the preview
Go deeper on Elutia.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Elutia.